Cargando…
Immunotherapy: Is it different for sarcomas?
The Janus-faced roles of macrophages in cancer imply both tumor-suppressive and -stimulating actions of these innate immune cells. Whereas the balance is toward tumor promotion in most epithelial cancers, we have recently shown that osteosarcoma metastasis seems to be inhibited by macrophages. Here...
Autores principales: | Cleton-Jansen, Anne-Marie, Buddingh, Emilie P., Lankester, Arjan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376989/ https://www.ncbi.nlm.nih.gov/pubmed/22720262 http://dx.doi.org/10.4161/onci.1.2.18345 |
Ejemplares similares
-
NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target
por: Lai, Jin-Ping, et al.
Publicado: (2012) -
When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma
por: Messaoudene, Meriem, et al.
Publicado: (2014) -
Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages
por: Cavnar, Michael J, et al.
Publicado: (2014) -
Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012) -
Shock block for improved immunotherapy
por: Rao, Aparna, et al.
Publicado: (2012)